- Prognostication of early-onset endometrioid endometrial cancer based on genome-wide DNA methylation profiles
-
Hirano T, Arai E, Fujimoto M, Nakayama Y, Tian Y, Ito N, Makabe T, Yamagami W, Susumu N, Aoki D, Kanai Y
- KMID: 2537965
- J Gynecol Oncol.
- 2022 Nov;33(6):e74.
- doi: 10.3802/jgo.2022.33.e74
Objective The aim of this study was to establish criteria that would indicate whether fertility preservation therapy would likely be safe for patients aged 40 years or less with endometrioid endometrial... -
- CITED
-
- Close
- SHARE
-
- Close
- The trend and outcome of postsurgical therapy for high-risk early-stage cervical cancer with lymph node metastasis in Japan: a report from the Japan Society of Gynecologic Oncology (JSGO) guidelines evaluation committee
-
Ikeda M, Shida M, Shigeta S, Nagase S, Takahashi F, Yamagami W, Katabuchi H, Yaegashi N, Aoki D, Mikami M
- KMID: 2526401
- J Gynecol Oncol.
- 2021 May;32(3):e44.
- doi: 10.3802/jgo.2021.32.e44
Objective: The Japan Society of Gynecologic Oncology published the first guidelines for the treatment of cervical cancer in 2007. The aim of this research was to evaluate the influence of... -
- CITED
-
- Close
- SHARE
-
- Close
- The first-round results of a populationbased cohort study of HPV testing in Japanese cervical cancer screening: baseline characteristics, screening results, and referral rate
-
Kono K, Morisada T, Saika K, Aoki ES, Miyagi E, Ito K, Takahashi H, Nakayama T, Saito H, Aoki D
- KMID: 2526389
- J Gynecol Oncol.
- 2021 May;32(3):e29.
- doi: 10.3802/jgo.2021.32.e29
Objective: In 2013, a cohort study aimed to clarify the positive and negative effects of introducing the human papillomavirus (HPV) testing for population-based cervical cancer screening has been launched in... -
- CITED
-
- Close
- SHARE
-
- Close
- Lymphadenectomy issues in endometrial cancer
-
Konno Y, Asano H, Shikama A, Aoki D, Tanikawa M, Oki A, Horie K, Mitsuhashi A, Kikuchi A, Tokunaga H, Terao Y, Satoh T, Ushijima K, Ishikawa M, Yaegashi N, Watari H
- KMID: 2526370
- J Gynecol Oncol.
- 2021 Mar;32(2):e25.
- doi: 10.3802/jgo.2021.32.e25
Objectives: This review aims to introduce preoperative scoring systems to predict lymph node metastasis (LNM) and ongoing clinical trials to investigate the therapeutic role of lymphadenectomy for endometrial cancer. Methods: We... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of lymphadenectomy on the treatment of endometrial cancer using data from the JSOG cancer registry
-
Saotome K, Yamagami W, Machida H, Ebina Y, Kobayashi Y, Tabata T, Kaneuchi M, Nagase S, Enomoto T, Aoki D, Mikami M
- KMID: 2511568
- Obstet Gynecol Sci.
- 2021 Jan;64(1):80-89.
- doi: 10.5468/ogs.20186
Objective Regional lymph node (LN) dissection is a standard surgical procedure for endometrial cancer, but there is currently no clear consensus on its therapeutic significance. We aimed to determine the... -
- CITED
-
- Close
- SHARE
-
- Close
- The post-progression survival of patients with recurrent or persistent ovarian clear cell carcinoma: results from a randomized phase III study in JGOG3017/GCIG
-
Kondo E, Tabata T, Suzuki N, Aoki D, Yahata H, Kotera Y, Tokuyama O, Fujiwara K, Kimura E, Terauchi F, Sumi T, Okamoto A, Yaegashi N, Enomoto T, Sugiyama T
- KMID: 2512059
- J Gynecol Oncol.
- 2020 Nov;31(6):e94.
- doi: 10.3802/jgo.2020.31.e94
Objective: In this study we sought to investigate the clinical factors that affect postprogression survival (PPS) in patients with recurrent or persistent clear cell carcinoma (CCC). We utilized the JGOG3017/Gynecological Cancer... -
- CITED
-
- Close
- SHARE
-
- Close
- Study of upfront surgery versus neoadjuvant chemotherapy followed by interval debulking surgery for patients with stage IIIC and IV ovarian cancer, SGOG SUNNY (SOC-2) trial concept
-
Jiang R, Zhu J, Kim JW, Liu J, Kato K, Kim HS, Zhang Y, Zhang P, Zhu T, Aoki D, Yu A, Chen X, Wang X, Zhu D, Zhang W, Jia H, Shi T, Gao W, Yin S, Feng Y, Xiang L, Okamoto A, Zang R
- KMID: 2511991
- J Gynecol Oncol.
- 2020 Sep;31(5):e86.
- doi: 10.3802/jgo.2020.31.e86
Background: Two randomized phase III trials (EORTC55971 and CHORUS) showed similar progression-free and overall survival in primary or interval debulking surgery in ovarian cancer, however both studies had limitations with... -
- CITED
-
- Close
- SHARE
-
- Close
- Erratum: Author Correction. Management of ovarian cancer patients in affected areas during COVID-19 pandemic: Japan and Korea
-
Kobayashi Y, Suh DH, Tsuji K, Kim JY, Shin S, Aoki D, Kim JW
- KMID: 2511994
- J Gynecol Oncol.
- 2020 Sep;31(5):e87.
- doi: 10.3802/jgo.2020.31.e87
-
- CITED
-
- Close
- SHARE
-
- Close
- Lymphadenectomy for primary ovarian cancer: a systematic review and meta-analysis
-
Chiyoda T, Sakurai M, Satoh T, Nagase S, Mikami M, Katabuchi H, Aoki D
- KMID: 2511979
- J Gynecol Oncol.
- 2020 Sep;31(5):e67.
- doi: 10.3802/jgo.2020.31.e67
Objective: To assess the effectiveness of lymphadenectomy at primary debulking surgery (PDS) on the survival of patients with epithelial ovarian cancer (EOC). Methods: We searched PubMed, Ichushi, and the Cochrane Library.... -
- CITED
-
- Close
- SHARE
-
- Close
- A retrospective study for investigating the relationship between old and new staging systems with prognosis in ovarian cancer using gynecologic cancer registry of Japan Society of Obstetrics and Gynecology (JSOG): disparity between serous carcinoma and clear cell carcinoma
-
Yamagami W, Nagase S, Takahashi F, Ino K, Hachisuga T, Mikami M, Enomoto T, Katabuchi H, Aoki D
- KMID: 2511956
- J Gynecol Oncol.
- 2020 Jul;31(4):e45.
- doi: 10.3802/jgo.2020.31.e45
Objective: International Federation of Gynecology and Obstetrics (FIGO) staging for ovarian, fallopian tube, and peritoneal cancers was revised in 2014. The aim of this study is to clarify whether the... -
- CITED
-
- Close
- SHARE
-
- Close
- Management of ovarian cancer patients in affected areas during COVID-19 pandemic: Japan and Korea
-
Kobayashi , Suh DH, Aoki D, Kim JW
- KMID: 2500490
- J Gynecol Oncol.
- 2020 Apr;31(3):e65.
- doi: 10.3802/jgo.2020.31.e65
-
- CITED
-
- Close
- SHARE
-
- Close
- Significance of PD-L1 expression in carbon-ion radiotherapy for uterine cervical adeno/adenosquamous carcinoma
-
Iijima M, Okonogi N, Nakajima N, Morokoshi , Kanda H, Yamada T, Kobayashi , Banno K, Wakatsuki , Yamada S, Kamada T, Aoki D, Hasegawa S
- KMID: 2470870
- J Gynecol Oncol.
- 2020 Mar;31(2):e19.
- doi: 10.3802/jgo.2020.31.e19
OBJECTIVE: Programmed cell death-ligand 1 (PD-L1) is expressed in tumor cells and has been shown to predict clinical outcomes of several types of malignancies. The aim of this study was... -
- CITED
-
- Close
- SHARE
-
- Close
- LAMC1 is a prognostic factor and a potential therapeutic target in endometrial cancer
-
Kunitomi H, Kobayashi , Wu RC, Takeda T, Tominaga E, Banno K, Aoki D
- KMID: 2470864
- J Gynecol Oncol.
- 2020 Mar;31(2):e11.
- doi: 10.3802/jgo.2020.31.e11
OBJECTIVE: With the emerging significance of genetic profiles in the management of endometrial cancer, the identification of tumor-driving genes with prognostic value is a pressing need. The LAMC1 gene, encoding... -
- CITED
-
- Close
- SHARE
-
- Close
- Japan Society of Gynecologic Oncology 2018 guidelines for treatment of uterine body neoplasms
-
Yamagami W, Mikami M, Nagase S, Tabata T, Kobayashi Y, Kaneuchi M, Kobayashi H, Yamada H, Hasegawa K, Fujiwara H, Katabuchi H, Aoki D
- KMID: 2465192
- J Gynecol Oncol.
- 2020 Jan;31(1):e18.
- doi: 10.3802/jgo.2020.31.e18
The Fourth Edition of the Guidelines for Treatment of Uterine Body Neoplasm was published in 2018. These guidelines include 9 chapters: 1. Overview of the guidelines, 2. Initial treatment for... -
- CITED
-
- Close
- SHARE
-
- Close
- Current state and outlook for drug repositioning anticipated in the field of ovarian cancer
-
Kobayashi , Banno K, Kunitomi H, Tominaga E, Aoki D
- KMID: 2429579
- J Gynecol Oncol.
- 2019 Jan;30(1):e10.
- doi: 10.3802/jgo.2019.30.e10
Ovarian cancer is the seventh most common cancer and the eighth most common cause of cancer mortality in women. Although standard chemotherapy is the established treatment for ovarian cancer, the... -
- CITED
-
- Close
- SHARE
-
- Close
- Screening for Lynch syndrome using risk assessment criteria in patients with ovarian cancer
-
Takeda T, Tsuji K, Banno K, Yanokura M, Kobayashi , Tominaga E, Aoki D
- KMID: 2409933
- J Gynecol Oncol.
- 2018 May;29(3):e29.
- doi: 10.3802/jgo.2018.29.e29
OBJECTIVE: Lynch syndrome is a cancer predisposition syndrome caused by germline mutation of DNA mismatch repair (MMR) genes. Lynch syndrome only causes about 0.4% of cases of ovarian cancer, which... -
- CITED
-
- Close
- SHARE
-
- Close
- The 5th Biennial Meeting of the Asian Society of Gynecologic Oncology, November 30th to December 2nd, 2017
-
Tominaga E, Kobayashi , Aoki D
- KMID: 2404023
- J Gynecol Oncol.
- 2018 Mar;29(2):e33.
- doi: 10.3802/jgo.2018.29.e33
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of institutional accreditation by the Japan Society of Gynecologic Oncology on the treatment and survival of women with cervical cancer
-
Mikami M, Shida M, Shibata T, Katabuchi , Kigawa J, Aoki D, Yaegashi N
- KMID: 2404018
- J Gynecol Oncol.
- 2018 Mar;29(2):e23.
- doi: 10.3802/jgo.2018.29.e23
OBJECTIVE: The Japan Society of Gynecologic Oncology (JSGO) initiated a nation-wide training system for the education and certification for gynecologic oncologists in 2005. To assess the impact of the quality... -
- CITED
-
- Close
- SHARE
-
- Close
- Is repeated high-dose medroxyprogesterone acetate (MPA) therapy permissible for patients with early stage endometrial cancer or atypical endometrial hyperplasia who desire preserving fertility?
-
Yamagami W, Susumu N, Makabe T, Sakai K, Nomura H, Kataoka F, Hirasawa A, Banno K, Aoki D
- KMID: 2404016
- J Gynecol Oncol.
- 2018 Mar;29(2):e21.
- doi: 10.3802/jgo.2018.29.e21
OBJECTIVE: Reports on the repeated administration of medroxyprogesterone acetate (MPA) for intrauterine recurrence after fertility-preserving therapy for atypical endometrial hyperplasia (AEH) and early grade 1 endometrioid carcinoma (G1) are lacking.... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical statistics of gynecologic cancers in Japan
-
Yamagami W, Nagase S, Takahashi , Ino K, Hachisuga , Aoki D, Katabuchi
- KMID: 2413460
- J Gynecol Oncol.
- 2017 Mar;28(2):e32.
- doi: 10.3802/jgo.2017.28.e32
Cervical, endometrial, and ovarian cancers, have both high morbidity and mortality among the gynecologic malignant tumors in Japan. The present study was conducted using both the population-based cancer registry and... -
- CITED
-
- Close
- SHARE
-
- Close
